Literature DB >> 25664202

Inpatient detoxification from a synthetic cannabinoid and control of postdetoxification cravings with naltrexone.

Christopher J C Rodgman1, Christopher D Verrico1, Ray B Worthy1, Erica E Lewis1.   

Abstract

Entities:  

Year:  2014        PMID： 25664202      PMCID： PMC4318662          DOI： 10.4088/PCC.13l01594

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  6 in total

1.  From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol.

Authors:  Fernando A Wagner; James C Anthony
Journal:  Neuropsychopharmacology       Date:  2002-04       Impact factor: 7.853

Review 2.  Advances in the field of cannabinoid--opioid cross-talk.

Authors:  Patricia Robledo; Fernando Berrendero; Andrés Ozaita; Rafael Maldonado
Journal:  Addict Biol       Date:  2008-06       Impact factor: 4.280

Review 3.  Spicing things up: synthetic cannabinoids.

Authors:  Max Spaderna; Peter H Addy; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

4.  Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.

Authors:  Ziva D Cooper; Margaret Haney
Journal:  Psychopharmacology (Berl)       Date:  2010-05-19       Impact factor: 4.530

5.  [Six-month follow-up study of drug treatment for cannabis addiction: comparison study of four drugs].

Authors:  Netta Shoenfeld; Dana Bodnik; Oded Rosenberg; Moshe Kotler; Pinhas Dannon
Journal:  Harefuah       Date:  2011-12

6.  The synthetic cannabinoid withdrawal syndrome.

Authors:  Nicholas Nacca; Deepak Vatti; Ross Sullivan; Payal Sud; Mark Su; Jeanna Marraffa
Journal:  J Addict Med       Date:  2013 Jul-Aug       Impact factor: 3.702
  6 in total
  6 in total

Review 1.  Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists.

Authors:  Eun Yong Chung; Hye Jin Cha; Hyun Kyu Min; Jaesuk Yun
Journal:  Arch Pharm Res       Date:  2021-04-02       Impact factor: 4.946

2.  [INCREMENT]9-Tetrahydrocannabinol discriminative stimulus effects of AM2201 and related aminoalkylindole analogs in rats.

Authors:  Torbjörn U C Järbe; Roger S Gifford; Alexander Zvonok; Alexandros Makriyannis
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

3.  Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports.

Authors:  Michal Ordak; Aleksandra Zmysłowska; Miłosz Bielski; Daniel Rybak; Maja Tomaszewska; Katarzyna Wyszomierska; Aleksandra Kmiec; Natalia Garlicka; Maria Zalewska; Michal Zalewski; Tadeusz Nasierowski; Elzbieta Muszynska; Magdalena Bujalska-Zadrozny
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

Review 4.  Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal.

Authors:  Ziva D Cooper
Journal:  Curr Psychiatry Rep       Date:  2016-05       Impact factor: 5.285

Review 5.  Management of nightmares in patients with posttraumatic stress disorder: current perspectives.

Authors:  Ali A El-Solh
Journal:  Nat Sci Sleep       Date:  2018-11-26

Review 6.  Emerging drugs of abuse: current perspectives on synthetic cannabinoids.

Authors:  Danièle Debruyne; Reynald Le Boisselier
Journal:  Subst Abuse Rehabil       Date:  2015-10-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.